Loading

Short Communication Open Access
Volume 2 | Issue 1 | DOI: https://doi.org/10.33696/Signaling.2.037

Neoadjuvant Therapy (NAT) in Localized Pancreatic Cancer: Should We Do It and What Should We Do?

  • 1Northwell Health Cancer Institute, Lake Success, NY 11042, USA
+ Affiliations - Affiliations

Corresponding Author

Muhammad Wasif Saif, wsaif@northwell.edu

Received Date: January 26, 2021

Accepted Date: March 02, 2021

Keywords

Chemotherapy, Neoadjuvant therapy, Pancreatic adenocarcinoma, Pancreatoduodenectomy, surgery, Gemcitabine, Oxaliplatin

Author Information X